GlassScriptPhysician profile
Angela Kim
NPI 1275935975
$533.54
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.74 · 2024: $251 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $121.63 | 2025 | |
| Hologic Sales and Service, LLC | $64.55 | 2024-2025 | Myosure Tissue Removal Device, Omni Hysteroscope, Novasure |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $63.23 | 2024 | Siliq, Jublia, Duobrii |
| Biogen, INC. | $59.94 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.26 | 2024-2025 | |
| Minerva Surgical, INC | $45.71 | 2024 | |
| Meditrina | $26.81 | 2025 | |
| Sumitomo Pharma America, INC. | $22.97 | 2025 | Myfembree |
| Aspira Women'S Health INC | $22.22 | 2024 | Ova1 |
| Merck Sharp & Dohme LLC | $22.11 | 2022 | |
| Pfizer INC. | $18.48 | 2024 | |
| Organon LLC | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.